Celebrex lawsuits follow the Vioxx lawsuit approach

Heart-broken family members of those killed by Vioxx are currently trying to evaluate their legal options with Vioxx attorneys and determining if they should join class action lawsuits filed against Merck. Those that have been injured by Vioxx are in the same situation. These are not easy times for these people particularly with the holidays around. (Related article: Attorneys soothe the frayed nerves of Vioxx victims)

Now it seems that Pfizer may be subject to class action lawsuits with regards to Celebrex. While no definitive data is available yet if Celebrex caused deaths (Vioxx reportedly killed tens of thousands of people worldwide), but recent studies indicate that Celebrex increases the risk of heart attacks. And these are the people who are looking to join class action lawsuits. CTV and Associated Press are reporting that Celebrex class action lawsuits are already being filed against Pfizer in the United States. Now a Toronto law firm has launched a $1.5 billion class-action lawsuit against Pfizer on behalf of all Canadians who took Celebrex. The firm McPhadden Samac Merner Darling, which is launching the suit, is claiming that Pfizer misrepresented information about its drug. The lead plaintiff is a Mississauga, Ontario woman who claims she lost earnings after developing an irregular heartbeat and cardiovascular problems after taking Celebrex. (Related article: Pfizer reaffirms safety of Celebrex)

Apart for Vioxx class action lawsuit plaintiffs, Celebrex class action lawsuits plaintiffs have a lot of company from Pfizer shareholders and 401(k) retirement plan participants because of possible violations of the Employee Retirement Income Security Act of 1974 (ERISA). Emerson Poynter LLP; Stull, Stull & Brody; Murray, Frank & Sailer LLP; Keller Rohrback L.L.P. Johnson & Perkinson; Finkelstein, Thompson & Loughran; Wolf Haldenstein Adler Freeman & Herz LLP; and Schatz & Nobel, are some of the Celebrex attorneys in the process of either getting ready for securities related lawsuits against Pfizer or have already filed complaints with the courts in the United States. In other words, it seems that there is already reasonable evidence against Pfizer that it may have provided misleading information about its drugs to both patients and shareholders.

How to find a Celebrex attorney?

Since there are a lot of similarities between Vioxx and Celebrex (they are both Cox-2 drugs), and even more obvious similarities in how Merck and Pfizer have handled the situation, many Vioxx attorneys are also starting to take on Celebrex cases. It may be important to note that since Vioxx has been recalled and it is well established that tens of thousands of Vioxx patients are either dead or seriously injured, the case against Vioxx manufacturer Merck is very strong. On the other hand, the FDA is still evaluating if Celebrex should be recalled. If Celebrex is recalled, then case against Pfizer will be much stronger.

In the meantime, you may want to discuss your case with an attorney, particularly if you switched from Vioxx to Celebrex. Quick action in this matter is important because when Congress starts its new session in January 2005, it is likely to take Class Action Reform Act being proposed by President Bush that will take away the right of American people to sue drugmakers even if they make deadly drugs.

Recommended article: How to find a good Vioxx/Celebrex attorney?